, Singapore

Noble chairman pumps more cash into his struggling firm

He bought 20 million shares in two days.

Embattled Noble Group’s founder and chairman Richard Elman is putting his money where his mouth is. The commodity trader’s CEO snapped up twenty million shares in just two trading days, in a bold show of confidence for his doubly-junked firm.

On Monday, Elman spent $3.34 million for 10 million shares, raising his stake to 22.13%. This follows a similar move on Friday, at which he also bought 10 million shares for $3.19 million.

Noble Group had a bad start to the year after it was cut to junk status by ratings agencies Standard and Poor’s and Moody’s. The stock is now trading at its lowest level in years.

Despite the back-to-back downgrades, Noble remains confident that the US$750m sale of its agribusiness arm Noble Agri will be enough to bring back the company’s investment grade status.

On a bourse filing Tuesday, Noble said that it would hold a special general meeting on January 28 to get shareholders’ permission to sell Noble Agri. The deal is expected to complete by February. 

Join Singapore Business Review community
Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Top News

DBS and OCBC expected to deliver steady Q1 net profits
Their net interest margins will ease as a result of their Hong Kong loans.
Singapore's maritime cluster navigates towards digital, green future
Adapting to emerging challenges, such as the adoption of alternative fuels, is deemed crucial for the country's maritime sector.
Shipping & Marine
SCG and A*STAR unveil joint labs for cellular immunotherapy enhancement
The partnership has a funding of nearly $30m supported under Singapore's Research, Innovation and Enterprise 2025 plan.
Healthcare